Bi-Layer Joint Health Tablets

With a rise in aging population, and an increase in obesity the world over, it’s critical to look at one of the leading causes of disability, in particular among US adults – arthritis. Arthritis is an umbrella term encompassing numerous conditions affecting joints and connective tissues. Currently, a little over 50 million adults in the United States of America are affected, and projections show nearly 70 million by the year 2030. In addition, adults age 50 and over, 55% are currently treating some form of joint pain and stiffness, while 48% are specifically treating arthritis.

bilayerjoints-whitepaper

Those 50 million adults have self-reported doctor diagnosed arthritis, while 21 million have arthritis-attributable activity limitation. Some of the numbers are staggering, data from 2003 suggests total attributable cost to arthritis around $128 billion, $81 billion in direct medical expenses and $47 billion in indirect costs such as lost wages.4 Here are a few more numbers to consider, 44 million outpatient visits, nearly 1 million hospitalizations, and a little over 9,300 deaths reported.

Sabinsa Corporation may use your contact data to keep you informed of its products and services by email. You can withdraw your marketing consent at any time by clicking the unsubscribe link in such email or by sending an email to dataprivacy@sabinsa.com. More information on our processing can be found in our Privacy Notice. By submitting this form, you acknowledge that you have read and understand our Privacy Policy.


    VISIT US

  • Sabinsa Canada Inc.
    6800 Kitimat Road, Unit 28,
    Mississauga, ON L5N 5M1
    Canada

  • +1 905-286-6616
  • +1 437-988-1663
  • info@sabinsa.ca

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos
Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.